Expand APM Menu
APM MENU

APM Latest Press Releases

-- March 27, 2023 --

Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group Business Wire 7:00 AM

-- March 17, 2023 --

Aptorum Group Limited and ASP Isotopes Inc. Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R) ACCESSWIRE 8:15 AM

-- March 3, 2023 --

Aptorum Group Announces Completion of End of Phase 1 (EOP1) Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma Business Wire 7:30 AM
Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on its ALS-4, a First-in-Class Small Molecule Drug Targeting Methicillin Resistant Staphylococcus Aureus Business Wire 7:30 AM

-- March 2, 2023 --

Aptorum Group Launches NativusWell, a Novel Nutraceutical for Menopause, in China Business Wire 7:30 AM

-- February 10, 2023 --

Aptorum Group Regains Compliance with Nasdaq Minimum Bid Price and Receives Nasdaq Notification of Minimum Market Value of Publicly Held Shares Deficiency Business Wire 4:30 PM

-- February 6, 2023 --

Aptorum Group Limited to Hold Special Extraordinary Meeting of Shareholders on February 21, 2023 Business Wire 10:08 AM

-- January 20, 2023 --

Aptorum Group Announces 1-for-10 Reverse Stock Split Business Wire 8:00 AM

-- January 4, 2023 --

Aptorum Group Announces Publication of a Co-authored Paper on its PathsDx Technology - a Rapid-Turnaround Low-Depth Unbiased Metagenomics Sequencing Workflow for Liquid Biopsy based Diagnosis of Infectious Diseases on Illumina Platforms Business Wire 9:00 AM

-- December 22, 2022 --

Aptorum Group Limited Announces Results of 2022 Annual General Meeting of Shareholders Business Wire 8:00 AM

-- December 16, 2022 --

Aptorum Group Announces Completion of $3 Million Convertible Note due 2023 Business Wire 8:00 AM

-- December 9, 2022 --

Aptorum Group Announces Offering of $3 Million Convertible Note due 2023 Business Wire 7:00 AM

-- November 25, 2022 --

Aptorum Group Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) ACCESSWIRE 8:31 AM
Aptorum Announces Publication of a Co-authored Paper on Development and Validation of a Sensitive Liquid Chromatography with Time-Of-Flight Mass Spectrometry Assay for In Vivo Pharmacokinetic Study of Epigallocatechin-gallate octaacetate (Pro-EGCG) Business Wire 8:00 AM

-- November 18, 2022 --

Aptorum Group Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency Business Wire 5:30 PM

-- November 8, 2022 --

Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 21, 2022 Business Wire 6:00 AM